Annovis Bio, Inc. (ANVS) Operating income 2019–2025
Annovis Bio, Inc. (ANVS) annual operating income history from SEC filings — each fiscal year as reported.
-$29.7MFY2025 · since FY2019: -$1.6M → -$29.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.7M | -11.2% |
| FY2024 | -$26.7M | +40.7% |
| FY2023 | -$45.0M | -76.5% |
| FY2022 | -$25.5M | -75.5% |
| FY2021 | -$14.5M | -118.9% |
| FY2020 | -$6.6M | -313.6% |
| FY2019 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANVS financial trends
ANVS RevenueANVS Net incomeANVS Net marginANVS Gross profitANVS Gross marginANVS Operating marginANVS Operating cash flowANVS Free cash flowANVS Capital expendituresANVS Return on equityANVS Stock buybacksANVS Dividends paidANVS Total assetsANVS Total liabilitiesANVS Shareholders’ equityANVS overview →